My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 135

    1.

    Risk factors, risk prediction, and the apolipoprotein B-apolipoprotein A-I ratio.

    Berkwits M, Guallar E.

    Ann Intern Med. 2007 May 1;146(9):677-9. No abstract available. PMID: 17470836 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy.

    Walldius G, Jungner I.

    J Intern Med. 2004 Feb;255(2):188-205. Review.PMID: 14746556 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Evaluation of the coronary risk: is it enough to asses ApoB/ApoA1 ratio only or is plasma lipoprotein concentration still necessary?]

    Cybulska B.

    Kardiol Pol. 2005 Feb;62(2):153-6. Review. Polish. No abstract available. PMID: 15815801 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Apolipoprotein B and A-I: cardiovascular risk factor?]

    Forti N, Diament J.

    Rev Assoc Med Bras. 2007 May-Jun;53(3):276-82. Review. Portuguese. PMID: 17665079 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Lipid profile in the acute phase of coronary artery disease.

    Batalla A, Reguero JR.

    Int J Cardiol. 2001 Sep-Oct;80(2-3):265. No abstract available. PMID: 11676391 [PubMed - indexed for MEDLINE]Related articles

    6.

    Apolipoprotein A1 and B.

    Sniderman AD, Marcovina SM.

    Clin Lab Med. 2006 Dec;26(4):733-50. Review.PMID: 17110237 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Should apolipoproteins be the first choice in routine health care?]

    Järhult B, Lindström K.

    Lakartidningen. 2007 Oct 17-23;104(42):3124. Swedish. No abstract available. PMID: 17985715 [PubMed - indexed for MEDLINE]Related articles

    8.

    Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.

    Marcovina S, Packard CJ.

    J Intern Med. 2006 May;259(5):437-46. Review.PMID: 16629849 [PubMed - indexed for MEDLINE]Related articles

    9.

    Apolipoproteins B and A-I as predictors of risk of coronary artery disease.

    Srinivasan SR, Berenson GS.

    Lancet. 2001 Dec 15;358(9298):2012-3. No abstract available. PMID: 11755602 [PubMed - indexed for MEDLINE]Related articles

    10.

    Apo B/apo A-I ratio and cardiovascular risk prediction.

    Lima LM, Carvalho MG, Sousa MO.

    Arq Bras Cardiol. 2007 Jun;88(6):e187-90. Review. English, Portuguese. No abstract available. PMID: 17664987 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies.

    Thompson A, Danesh J.

    J Intern Med. 2006 May;259(5):481-92. Review.PMID: 16629854 [PubMed - indexed for MEDLINE]Related articles

    12.

    The apolipoprotein b/apolipoprotein AI ratio in the metabolic syndrome-should we start using it?

    Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F.

    J Cardiometab Syndr. 2008 Winter;3(1):53-4. No abstract available. PMID: 18326976 [PubMed - indexed for MEDLINE]Related articles

    13.

    Apo B/Apo A-I ratio in central and peripheral arterial diseases.

    Lima LM, Carvalho MG, Sabino Ade P, Mota AP, Fernandes AP, Sousa MO.

    Arq Bras Endocrinol Metabol. 2007 Oct;51(7):1160-5.PMID: 18157393 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA study.

    Pitsavos C, Panagiotakos DB, Skoumas J, Papadimitriou L, Stefanadis C.

    Angiology. 2008 Jun-Jul;59(3):335-41. Epub 2008 Apr 2.PMID: 18388068 [PubMed - indexed for MEDLINE]Related articles

    15.

    Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.

    Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS.

    JAMA. 2007 Aug 15;298(7):776-85.PMID: 17699011 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Apolipoprotein B/A1 and risk of cardiovascular disease.

    Lind L.

    Lancet. 2008 Jul 19;372(9634):185-6. No abstract available. PMID: 18640440 [PubMed - indexed for MEDLINE]Related articles

    17.

    Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy.

    Walldius G, Jungner I.

    Eur Heart J. 2005 Feb;26(3):210-2. Epub 2004 Dec 15. No abstract available. PMID: 15618031 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Apolipoproteins B and AI and the risk of ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease.

    Koren-Morag N, Goldbourt U, Graff E, Tanne D.

    J Neurol Sci. 2008 Jul 15;270(1-2):82-7. Epub 2008 Apr 2.PMID: 18377938 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks]

    Onat A, Ozhan H, Can G, Hergenç G, Karabulut A, Albayrak S.

    Anadolu Kardiyol Derg. 2007 Jun;7(2):128-33. Turkish. PMID: 17513206 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Apolipoproteins A-I and B-markers in coronary risk evaluation.

    Agoston-Coldea L, Zdrenghea D, Pop D, Crăciun A, Rusu ML, Mocan T.

    Rom J Intern Med. 2007;45(3):251-8.PMID: 18333357 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity